Working Paper 05-19 - L’industrie pharmaceutique en Belgique - Analyse de compétitivité

Bernadette Biatour and Chantal Kegels

Working Papers from Federal Planning Bureau, Belgium

Abstract: This Working Paper analyses the competitive position of the pharmaceutical industry over the 2000-2017 period. The evolution of price/cost competitiveness and non-cost competitiveness is studied based on a comparison with our neighbouring countries France, the Netherlands and Germany, and with Denmark, Ireland, Slovenia and Switzerland. The study also analyses a series of global factors and factors specific to the pharmaceutical industry that may influence competitiveness.

JEL-codes: H32 O32 O33 O38 (search for similar items in EconPapers)
Date: 2019-04-30
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.plan.be/uploaded/documents/201905091117590.WP_1905_11895.pdf version française (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Unavailable

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:fpb:wpaper:201905

Access Statistics for this paper

More papers in Working Papers from Federal Planning Bureau, Belgium Contact information at EDIRC.
Bibliographic data for series maintained by Dominique van der Wal ().